221 related articles for article (PubMed ID: 33113251)
1. Interleukin-9-secreting CD4
Gang H; Peng D; Hu Y; Tang S; Li S; Huang Q
APMIS; 2021 Feb; 129(2):91-102. PubMed ID: 33113251
[TBL] [Abstract][Full Text] [Related]
2. [The regulatory function of tumor-infiltrating Th9 cells to anti-tumor activity of CD8(+) T cells in patients with gastric cancer].
Sun PS; Gao ZJ; Fan LX; Liu YF; Chen BH; Mu SZ; Yan ZQ
Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1186-1193. PubMed ID: 36380667
[No Abstract] [Full Text] [Related]
3. Interleukin-35 Suppresses Interleukin-9-Secreting CD4
Zhang Q; Yang L; Liu S; Zhang M; Jin Z
Front Immunol; 2021; 12():645835. PubMed ID: 34177894
[TBL] [Abstract][Full Text] [Related]
4. Th9 cells promote antitumor immunity via IL-9 and IL-21 and demonstrate atypical cytokine expression in breast cancer.
You FP; Zhang J; Cui T; Zhu R; Lv CQ; Tang HT; Sun DW
Int Immunopharmacol; 2017 Nov; 52():163-167. PubMed ID: 28918288
[TBL] [Abstract][Full Text] [Related]
5. Th9 cells are subjected to PD-1/PD-L1-mediated inhibition and are capable of promoting CD8 T cell expansion through IL-9R in colorectal cancer.
Wang C; Lu Y; Chen L; Gao T; Yang Q; Zhu C; Chen Y
Int Immunopharmacol; 2020 Jan; 78():106019. PubMed ID: 31776089
[TBL] [Abstract][Full Text] [Related]
6. Circulating Th22 and Th9 levels in patients with acute coronary syndrome.
Lin YZ; Wu BW; Lu ZD; Huang Y; Shi Y; Liu H; Liu L; Zeng QT; Wang X; Ji QW
Mediators Inflamm; 2013; 2013():635672. PubMed ID: 24453425
[TBL] [Abstract][Full Text] [Related]
7. Characterization of CD4
Zhang X; Gao L; Meng K; Han C; Li Q; Feng Z; Chen L
Cell Immunol; 2018 May; 327():62-67. PubMed ID: 29454645
[TBL] [Abstract][Full Text] [Related]
8. CD100 modulates cytotoxicity of CD8
Li Y; Qin L; Bai Q; Zhang J; Chen R; Song K
BMC Immunol; 2021 Feb; 22(1):13. PubMed ID: 33593275
[TBL] [Abstract][Full Text] [Related]
9. Induction of granzyme B and T cell cytotoxic capacity by IL-2 or IL-15 without antigens: multiclonal responses that are extremely lytic if triggered and short-lived after cytokine withdrawal.
Tamang DL; Redelman D; Alves BN; Vollger L; Bethley C; Hudig D
Cytokine; 2006 Nov; 36(3-4):148-59. PubMed ID: 17188506
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-7 and interleukin-15 drive CD4+CD28null T lymphocyte expansion and function in patients with acute coronary syndrome.
Bullenkamp J; Mengoni V; Kaur S; Chhetri I; Dimou P; Astroulakis ZMJ; Kaski JC; Dumitriu IE
Cardiovasc Res; 2021 Jul; 117(8):1935-1948. PubMed ID: 32647892
[TBL] [Abstract][Full Text] [Related]
11. HBV-specific CD4+ cytotoxic T cells in hepatocellular carcinoma are less cytolytic toward tumor cells and suppress CD8+ T cell-mediated antitumor immunity.
Meng F; Zhen S; Song B
APMIS; 2017 Aug; 125(8):743-751. PubMed ID: 28493520
[TBL] [Abstract][Full Text] [Related]
12. High levels of costimulatory receptors OX40 and 4-1BB characterize CD4+CD28null T cells in patients with acute coronary syndrome.
Dumitriu IE; Baruah P; Finlayson CJ; Loftus IM; Antunes RF; Lim P; Bunce N; Kaski JC
Circ Res; 2012 Mar; 110(6):857-69. PubMed ID: 22282196
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-35 regulates peripheral T cell activity in patients with Kawasaki disease.
Sun M; Xing H
Int Immunopharmacol; 2021 Jul; 96():107642. PubMed ID: 33862556
[TBL] [Abstract][Full Text] [Related]
14. Differential development of CD4 and CD8 cytotoxic T cells (CTL) in PBMC across the leprosy spectrum; IL-6 with IFN-gamma or IL-2 generate CTL in multibacillary patients.
de la Barrera S; Finiasz DM; Fink S; Valdez R; Bottasso O; Balina LM; Sasiain MC
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):45-55. PubMed ID: 9207753
[TBL] [Abstract][Full Text] [Related]
15. Toll like Receptor 2 engagement on CD4
Karim AF; Reba SM; Li Q; Boom WH; Rojas RE
Eur J Immunol; 2017 Sep; 47(9):1513-1524. PubMed ID: 28665005
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory molecules that regulate expansion and restoration of HCV-specific CD4+ T cells in patients with chronic infection.
Raziorrouh B; Ulsenheimer A; Schraut W; Heeg M; Kurktschiev P; Zachoval R; Jung MC; Thimme R; Neumann-Haefelin C; Horster S; Wächtler M; Spannagl M; Haas J; Diepolder HM; Grüner NH
Gastroenterology; 2011 Oct; 141(4):1422-31, 1431.e1-6. PubMed ID: 21763239
[TBL] [Abstract][Full Text] [Related]
17. Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand.
Miura Y; Thoburn CJ; Bright EC; Hess AD
Biol Blood Marrow Transplant; 2004 Mar; 10(3):156-70. PubMed ID: 14993881
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-36gamma Mediates the
Zhou Y; Chen J; Bai S; Yang F; Yan R; Song Y; Yang B; Li C; Wang J
Viral Immunol; 2024; 37(1):24-35. PubMed ID: 38301135
[TBL] [Abstract][Full Text] [Related]
19. [The modulatory activity of T cell immunoglobulin and mucin domain-containing protein 3 on T lymphocytes in patients with chronic heart failure].
Yu HW; Dong YY; Dang YH
Zhonghua Yi Xue Za Zhi; 2020 May; 100(17):1315-1319. PubMed ID: 32375439
[No Abstract] [Full Text] [Related]
20. Interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) are necessary in the early stages of induction of CD4 and CD8 cytotoxic T cells by Mycobacterium leprae heat shock protein (hsp) 65 kD.
Sasiain MC; de la Barrera S; Fink S; Finiasz M; Alemán M; Fariña MH; Pizzariello G; Valdez R
Clin Exp Immunol; 1998 Nov; 114(2):196-203. PubMed ID: 9822276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
